When Can TTTS Start?
TTTS can manifest at any time during gestation in monochorionic twin pregnancies, though most cases are diagnosed in the mid-trimester, typically arising between 15 and 26 weeks gestation. 1, 2
Gestational Age Range
While the classic presentation occurs in the second trimester, the evidence demonstrates considerable variability:
- Earliest documented cases: TTTS has been reported as early as 11 weeks gestation 3
- Most common presentation: Between 15-26 weeks 2
- Mean diagnosis age in surveillance studies: Approximately 21 weeks (range 15-29 weeks) 4
- Late presentations: Can occur up to the third trimester, though less common after 28-30 weeks 4
Clinical Implications for Surveillance
Based on this timing, ultrasound surveillance must begin at 16 weeks gestation for all monochorionic diamniotic (MCDA) twin pregnancies and continue at least every 2 weeks until delivery. 1 This recommendation (GRADE 1C) from the 2024 Society for Maternal-Fetal Medicine guidelines reflects the understanding that TTTS can develop rapidly once the second trimester begins.
The 2025 North American Fetal Therapy Network consensus further specifies that surveillance should include assessment of maximum vertical pocket of amniotic fluid, bladder filling, and Doppler measurements (umbilical artery, ductus venosus, and MCA-PSV) starting at this 16-week threshold. 5
Early-Onset TTTS Considerations
Early-onset TTTS (diagnosed before 18 weeks) represents a particularly challenging subset with outcomes at the lower bound of the typical 60-90% survival range. 6 Research shows:
- Median gestational age at intervention for early-onset cases: 17+4 weeks (range 15+0 to 28+1) 6
- Overall survival in early-onset TTTS: 60-69% compared to better outcomes in later presentations 6
- The lack of therapeutic options before 16 weeks creates a management dilemma when diagnosis occurs in the late first trimester
Predictive Markers in First Trimester
Some evidence suggests that increased nuchal translucency discordance between twins at 11-14 weeks, particularly when combined with abnormal ductus venosus flow, may herald eventual TTTS development. 7 However, this remains investigational and does not change the standard surveillance initiation at 16 weeks.
Critical Pitfalls
- Do not delay surveillance past 16 weeks - the disease can progress rapidly once it begins
- After 28-30 weeks, TTTS development becomes less likely but surveillance should continue with a different focus on growth and well-being 4
- Increase surveillance frequency to weekly if you detect discordant maximum vertical pocket (>65% difference) or estimated fetal weight discordance (>25%) at any point 4
The key takeaway: while TTTS theoretically can start from late first trimester onward, structured surveillance beginning at 16 weeks captures the vast majority of clinically significant cases during the critical 16-26 week window when fetoscopic laser therapy is most effective.